Case Report
Primary Cutaneous Squamous Cell Carcinoma of Thigh A Case Report and Review of Literature
Vishwas D. Pai1*, Sushma V. Pai2, Vidhya Manohar3, Suvarna Ravindranath3 and Mahantesh. K. Math4
1Department of Surgical Oncology, Kerudi Cancer Hospital and Research Centre, Bagalkot 587101, Karnataka, India
2Department of Anesthesiology and Critical care, Kerudi Cancer Hospital and Research Centre, Bagalkot 587101, Karnataka, India
3Department of Pathology, SRL Diagnostics, Banagalore 560076, Karnataka, India
4Department of Plastic Surgery, Kerudi Cancer Hospital and Research Centre, Bagalkot 587101, Karnataka, India
- *Corresponding Author:
- Vishwas. D. Pai
Department of Surgical Oncology
Kerudi Cancer Hospital and Research Centre
Bagalkot 587101, Karnataka, India
Tel: +91-9449333502
E-mail: vishpai88@gmail.com
Received Date: January 20, 2016; Accepted Date: February 04, 2016; Published Date: February 12, 2016
Citation: Pai VD, Pai SV, Manohar V, Ravindranath S, Math MK (2016) Primary Cutaneous Squamous Cell Carcinoma of Thigh – A Case Report and Review of Literature. J Orthop Oncol 2:106. doi:10.4172/2472-016X.1000106
Copyright: © 2016 Pai VD, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Squamous cell carcinomas (SCC) are second most common cutaneous malignancy. Exposure to ultraviolet rays remains the single most important etiological factor. Although SCC can arise in unexposed areas these are typically associated with long standing ulcers and sinuses or immunosuppression. There are no randomized controlled trials on primary cutaneous SCC in general and in these rare subsites in particular. There is no consensus on the management of these tumours particularly the role of prophylactic lymph node dissection and role of adjuvant radiotherapy. The purpose of reporting this case is to critically review the literature for the current evidence for the management of primary cutaneous squamous cell carcinoma.
